Nexus between COVID-19 and periodontal disease
Over the past several decades, studies have demonstrated the existence of bi-directional relationships between periodontal disease and systemic conditions. Periodontitis is a polymicrobial and multifactorial disease involving both host and environmental factors. Tissue destruction is primarily associated with hyperresponsiveness of the host resulting in release of inflammatory mediators. Pro-inflammatory cytokines play a major role in bacterial stimulation and tissue destruction. In addition, these cytokines are thought to underlie the associations between periodontitis and systemic conditions. Current research suggests that increased release of cytokines from host cells, referred to as the cytokine storm, is associated with disease progression in patients with coronavirus disease 2019 (COVID-19). An intersection between periodontitis and pulmonary disease is biologically plausible. Hence, we reviewed the evidence linking COVID-19, cytokines, and periodontal disease. Plaque control is essential to prevent exchange of bacteria between the mouth and the lungs, reducing the risk of lung disease. Understanding these associations may help identify individuals at high risk and deliver appropriate care at early stages.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:49 |
---|---|
Enthalten in: |
The Journal of international medical research - 49(2021), 3 vom: 10. März, Seite 3000605211002695 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sukumar, Kanchana [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 02.04.2021 Date Revised 03.04.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.1177/03000605211002695 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM323017223 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM323017223 | ||
003 | DE-627 | ||
005 | 20231225183251.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1177/03000605211002695 |2 doi | |
028 | 5 | 2 | |a pubmed24n1076.xml |
035 | |a (DE-627)NLM323017223 | ||
035 | |a (NLM)33745336 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sukumar, Kanchana |e verfasserin |4 aut | |
245 | 1 | 0 | |a Nexus between COVID-19 and periodontal disease |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 02.04.2021 | ||
500 | |a Date Revised 03.04.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Over the past several decades, studies have demonstrated the existence of bi-directional relationships between periodontal disease and systemic conditions. Periodontitis is a polymicrobial and multifactorial disease involving both host and environmental factors. Tissue destruction is primarily associated with hyperresponsiveness of the host resulting in release of inflammatory mediators. Pro-inflammatory cytokines play a major role in bacterial stimulation and tissue destruction. In addition, these cytokines are thought to underlie the associations between periodontitis and systemic conditions. Current research suggests that increased release of cytokines from host cells, referred to as the cytokine storm, is associated with disease progression in patients with coronavirus disease 2019 (COVID-19). An intersection between periodontitis and pulmonary disease is biologically plausible. Hence, we reviewed the evidence linking COVID-19, cytokines, and periodontal disease. Plaque control is essential to prevent exchange of bacteria between the mouth and the lungs, reducing the risk of lung disease. Understanding these associations may help identify individuals at high risk and deliver appropriate care at early stages | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Coronavirus disease 2019 | |
650 | 4 | |a cytokine | |
650 | 4 | |a cytokine storm | |
650 | 4 | |a inflammation | |
650 | 4 | |a periodontitis | |
650 | 4 | |a severe acute respiratory syndrome coronavirus 2 | |
650 | 7 | |a IL10 protein, human |2 NLM | |
650 | 7 | |a IL6 protein, human |2 NLM | |
650 | 7 | |a Interleukin-6 |2 NLM | |
650 | 7 | |a Pathogen-Associated Molecular Pattern Molecules |2 NLM | |
650 | 7 | |a Tumor Necrosis Factor-alpha |2 NLM | |
650 | 7 | |a Interleukin-10 |2 NLM | |
650 | 7 | |a 130068-27-8 |2 NLM | |
650 | 7 | |a Interferon-gamma |2 NLM | |
650 | 7 | |a 82115-62-6 |2 NLM | |
700 | 1 | |a Tadepalli, Anupama |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of international medical research |d 1973 |g 49(2021), 3 vom: 10. März, Seite 3000605211002695 |w (DE-627)NLM000148504 |x 1473-2300 |7 nnns |
773 | 1 | 8 | |g volume:49 |g year:2021 |g number:3 |g day:10 |g month:03 |g pages:3000605211002695 |
856 | 4 | 0 | |u http://dx.doi.org/10.1177/03000605211002695 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 49 |j 2021 |e 3 |b 10 |c 03 |h 3000605211002695 |